By facilitating PTBP1-mediated alternative splicing of CD44 mRNA, CTC-490G23.2 upregulates the expression of CD44 variant isoform CD44v (8-10), which promotes cancer metastasis [79]. This evidence concerns the gene CD44 and cancer.